{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:31:35Z","timestamp":1791556295180,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Ministry of Health, Labor and Welfare of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We conducted retrospective cohort studies of patients with relapsing polychondritis (RP) twice in 2009 and 2019, using a physician questionnaire. We compared the patients\u2019 clinical statuses between the years. Age and gender were comparable between the two surveys. Mean disease duration was longer in 2019 survey (8.3\u00a0years) than that in 2009 survey (4.8\u00a0years, P\u2009&lt;\u20090.001). The mortality rate declined in 2019 survey compared with those in 2009 survey (from 9.2 to 1.6%, P\u2009&lt;\u20090.001). Incidence of airway involvement decreased in 2019 survey compared with that in 2009 survey (from 49 to 37%, P\u2009=\u20090.012). In 2019 survey, we found more frequent use of biological agents and immunosuppressants in patients with airway involvement. When we focused on RP patients with airway involvement, physicians in 2019 chose methotrexate and calcineurin inhibitors preferentially, compared with azathioprine and cyclophosphamide. Of note is that increased use of infliximab was observed in RP patients with airway involvement, but not in those without. Reduction of airway involvement and mortality in patients with RP was observed in 2019 survey. The reduction may associate with the frequent use of biologics including infliximab in RP patients with airway involvement.<\/jats:p>","DOI":"10.1038\/s41598-021-04493-0","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:04:32Z","timestamp":1641812672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009"],"prefix":"10.1038","volume":"12","author":[{"given":"Jun","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimito","family":"Kawahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"4493_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/sarh.2002.32586","volume":"31","author":"E Letko","year":"2002","unstructured":"Letko, E. et al. Relapsing polychondritis: A clinical review. Semin. Arthritis Rheum. 31, 384\u2013395. https:\/\/doi.org\/10.1053\/sarh.2002.32586 (2002).","journal-title":"Semin. Arthritis Rheum."},{"key":"4493_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam, L. P., O\u2019Hanlan, M. A., Bluestone, R. & Pearson, C. M. Relapsing polychondritis: Prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55, 193\u2013215 (1976).","journal-title":"Medicine (Baltimore)"},{"key":"4493_CR3","doi-asserted-by":"publisher","unstructured":"Michet, C.J. Jr., McKenna, C.H., Luthra, H.S. & O'Fallon, W.M. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann. Intern. Med. 104, 74\u201378. https:\/\/doi.org\/10.7326\/0003-4819-104-1-74 (1986).","DOI":"10.7326\/0003-4819-104-1-74"},{"key":"4493_CR4","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/art.39790","volume":"68","author":"J Dion","year":"2016","unstructured":"Dion, J. et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: Analysis of a recent series of 142 patients. Arthritis Rheumatol. 68, 2992\u20133001. https:\/\/doi.org\/10.1002\/art.39790 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"4493_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2492\/inflammregen.34.149","volume":"34","author":"H Oka","year":"2014","unstructured":"Oka, H., Yamano, Y., Shimizu, J., Yudoh, K. & Suzuki, N. A large-scale survey of patients with relapsing polychondritis in Japan. Inflamm. Regen. 34, 149\u2013156 (2014).","journal-title":"Inflamm. Regen."},{"key":"4493_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7326\/0003-4819-129-2-199807150-00011","volume":"129","author":"DE Trentham","year":"1998","unstructured":"Trentham, D. E. & Le, C. H. Relapsing polychondritis. Ann. Intern. Med. 129, 114\u2013122. https:\/\/doi.org\/10.7326\/0003-4819-129-2-199807150-00011 (1998).","journal-title":"Ann. Intern. Med."},{"key":"4493_CR7","doi-asserted-by":"publisher","unstructured":"Biya, J. et al. Assessment of TNF-\u03b1 inhibitors in airway involvement of relapsing polychondritis: A systematic review. Medicine (Baltimore) 98, e17768. https:\/\/doi.org\/10.1097\/MD.0000000000017768 (2019).","DOI":"10.1097\/MD.0000000000017768"},{"key":"4493_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-020-00141-8","volume":"4","author":"J Shimizu","year":"2020","unstructured":"Shimizu, J., Yamano, Y., Kawahata, K. & Suzuki, N. Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: Potential impact on patient monitoring. BMC Rheumatol. 4, 41. https:\/\/doi.org\/10.1186\/s41927-020-00141-8 (2020).","journal-title":"BMC Rheumatol."},{"key":"4493_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102353","volume":"18","author":"N de Montmollin","year":"2019","unstructured":"de Montmollin, N. et al. Tracheobronchial involvement of relapsing polychondritis. Autoimmun. Rev. 18, 102353. https:\/\/doi.org\/10.1016\/j.autrev.2019.102353 (2019).","journal-title":"Autoimmun. Rev."},{"key":"4493_CR10","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/annrheumdis-2017-212705","volume":"77","author":"G Moulis","year":"2018","unstructured":"Moulis, G. et al. Efficacy and safety of biologics in relapsing polychondritis: A French national multicentre study. Ann. Rheum. Dis. 77, 1172\u20131178. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212705 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"4493_CR11","doi-asserted-by":"publisher","unstructured":"Kemta Lekpa, F., Kraus, V.B. & Chevalier, X. Biologics in relapsing polychondritis: a literature review. Semin. Arthritis Rheum. 41, 712\u2013719. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.006 (2012).","DOI":"10.1016\/j.semarthrit.2011.08.006"},{"key":"4493_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4065\/81.6.772","volume":"81","author":"C Dib","year":"2006","unstructured":"Dib, C. et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: Overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin. Proc. 81, 772\u2013776. https:\/\/doi.org\/10.4065\/81.6.772 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"4493_CR13","first-page":"96","volume":"24","author":"M Zeuner","year":"1997","unstructured":"Zeuner, M. et al. Relapsing polychondritis: Clinical and immunogenetic analysis of 62 patients. J. Rheumatol. 24, 96\u2013101 (1997).","journal-title":"J. Rheumatol."},{"key":"4493_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semarthrit.2011.12.007","volume":"42","author":"SD Mathew","year":"2012","unstructured":"Mathew, S. D., Battafarano, D. F. & Morris, M. J. Relapsing polychondritis in the Department of Defense population and review of the literature. Relapsing polychondritis with isolated tracheal involvement and airway-only symptoms 42, 70\u201383. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.12.007 (2012).","journal-title":"Relapsing polychondritis with isolated tracheal involvement and airway-only symptoms"},{"key":"4493_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2133.1992.tb00135.x","volume":"127","author":"AD Ormerod","year":"1992","unstructured":"Ormerod, A. D. & Clark, L. J. Relapsing polychondritis-treatment with cyclosporin A. Br. J. Dermatol. 127, 300. https:\/\/doi.org\/10.1111\/j.1365-2133.1992.tb00135.x (1992).","journal-title":"Br. J. Dermatol."},{"key":"4493_CR16","doi-asserted-by":"publisher","unstructured":"Horv\u00e1th, A., et al. A nationwide study of the epidemiology of relapsing polychondritis. Clin. Epidemiol. 8, 211\u201330. https:\/\/doi.org\/10.2147\/CLEP.S91439 (2016).","DOI":"10.2147\/CLEP.S91439"},{"key":"4493_CR17","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/rheumatology\/kev240","volume":"54","author":"N Hazra","year":"2015","unstructured":"Hazra, N., Dregan, A., Charlton, J., Gulliford, M. C. & D\u2019Cruz, D. P. Incidence and mortality of relapsing polychondritis in the UK: A population-based cohort study. Rheumatology (Oxford) 54, 2181\u20132187. https:\/\/doi.org\/10.1093\/rheumatology\/kev240 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"4493_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038623","volume":"10","author":"H Tada","year":"2020","unstructured":"Tada, H. et al. Hokuriku-plus familial hypercholesterolaemia registry study: Rationale and study design. BMJ Open 10, e038623. https:\/\/doi.org\/10.1136\/bmjopen-2020-038623 (2020).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04493-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:49:19Z","timestamp":1669322959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04493-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-04493-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"465"}}